Replacing the mercury manometer with an oscillometric device in a hypertension clinic: Implications for clinical decision making

Journal of Human Hypertension

Volumn 25, Issue 11, 2011, Pages 692-698

  Stergiou, G S ^a   Lourida, P ^a   Tzamouranis, D ^a  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

Author keywords

electronic devices; mercury sphygmomanometer; oscillometric devices; treatment decision

Indexed keywords

MERCURY;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARM; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL DECISION MAKING; CROSS-SECTIONAL STUDY; FEMALE; HEALTH SERVICE; HOSPITAL; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OSCILLOMETRIC DEVICE; OSCILLOMETRY; SPHYGMOMANOMETER;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; EQUIPMENT DESIGN; FEMALE; GREECE; HUMANS; HYPERTENSION; MALE; MANOMETRY; MERCURY; MIDDLE AGED; OFFICE VISITS; OSCILLOMETRY; OUTPATIENT CLINICS, HOSPITAL; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; SPHYGMOMANOMETERS;

EID: 80054063638     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2010.107     Document Type: Article

References (29)

1. O'Brien E, Asmar R, Beilin L, Imai Y, Mallion JM, Mancia G et al. European Society of Hypertension recommendations for conventional, ambulatory and home blood pressure measurement. J Hypertens 2003; 21: 821-848. (Pubitemid 36677141)
2. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN et al. Recommendations for blood pressure measurement in humans and experimental animals: Part 1: Blood pressure measurement in humans: A statement for professionals from the subcommittee of professional and public education of the American Heart Association Council on High Blood Pressure Research. Hypertension 2005; 45: 142-161. (Pubitemid 40066429)
3. Mercury in measuring devices (Amendment of Council Directive 76/769/EEC) Directive 2007/51/EC of the European Parliament and of the Council of 25 September 2007. http://ec.europa.eu/enterprise/chemicals/ legislation/markrestr/ amendments-en.htm. (Accessed 2 June 2010).
4. Graves JW, Tibor M, Murtagh B, Klein L, Sheps SG. The Accoson greenlight 300, the first non-automated mercury-free blood pressure measurement device to pass the International Protocol for blood pressure measuring devices in adults. Blood Press Monit 2004; 9: 13-17. (Pubitemid 38429428)
5. Stergiou GS, Giovas PP, Gkinos CP, Tzamouranis DG. Validation of the A&D UM-101 professional hybrid device for office blood pressure measurement according to the International Protocol. Blood Press Monit 2008; 13: 37-42.
6. Tasker F, De Greeff A, Shennan AH. Development and validation of a blinded hybrid device according to the European Hypertension Society protocol: Nissei DM-3000. J Hum Hypertens 2010; 24: 609-616.
7. Asmar R, Khabouth J, Mattar J, Pecchioli V, Germano G. Validation of three professional devices measuring office blood pressure according to three different methods: The Omron BP10, the Omron HBP T105 and the Pic Indolor Professional. J Hypertens 2010; 28: 452-458.
8. Omboni S, Riva I, Giglio A, Caldara G, Groppelli A, Parati G. Validation of the Omron M5-I, R5-I and HEM- 907 automated blood pressure monitors in elderly individuals according to the International Protocol of the European Society of Hypertension. Blood Press Monit 2007; 12: 233-242. (Pubitemid 47356409)
9. Stergiou GS, Tzamouranis D, Protogerou A, Nasothimiou E, Kapralos C. Validation of the Microlife watch BP office professional device for office blood pressure measurement according to the International Protocol. Blood Press Monit 2008; 13: 299-303.
10. dabl Educational Trust. Devices for blood pressure measurement. http://www.dableducational.org. (Accessed 2 June 2010).
11. Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European Society of Hypertension guidelines for blood pressure monitoring at home: A summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 2008; 26: 1505-1526.
12. Pickering TG. What will replace the mercury sphygmomanometer? Blood Press Monit 2003; 8: 23-25. (Pubitemid 36343967)
13. Stergiou GS. How to cope with unreliable office blood pressure measurement? Am J Hypertens 2005; 18: 1519-1521. (Pubitemid 41814669)
14. Pickering TG. Should doctors still measure blood pressure? J Clin Hypertens 2006; 8: 394-396.
15. Pickering TG, Gerin W, Schwartz JE, Spruill TM, Davidson KW. Franz Volhard lecture: Should doctors still measure blood pressure? The missing patients with masked hypertension. J Hypertens 2008; 26: 2259-2267.
16. Myers MG, Godwin M. Automated measurement of blood pressure in routine clinical practice. J Clin Hypertens 2007; 9: 267-270.
17. Stergiou GS. Office blood pressure measurement with electronic devices: Has the time come? Am J Hypertens 2008; 21: 246. (Pubitemid 351323284)
18. Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR). Mercury sphygmomanometers in healthcare and the feasibility of alternatives. European commission, directorate general for 'health and consumers'. http://ec.europa.eu/health/ ph-risk/committees/04-scenihr/scenihr- opinions-en. htm#2. (Accessed 2 June 2010).
19. Wright JM, Mattu GS, Perry Jr. TL, Gelferc ME, Strange KD, Zorn A et al. Validation of a new algorithm for the BPM-100 electronic oscillometric office blood pressure monitor. Blood Press Monit 2001; 6: 161-165. (Pubitemid 32744590)
20. Mattu GS, Heran BS, Wright JM. Overall accuracy of the BpTRU-an automated electronic blood pressure device. Blood Press Monit 2004; 9: 47-52. (Pubitemid 38429433)
21. O'Brien E, Petrie J, Littler W, de Swiet M, Padfield PL, O'Malley K et al. The British Hypertension Society protocol for the evaluation of automated and semiautomated blood pressure measuring devices with special reference to ambulatory systems. J Hypertens 1990; 8: 607-619. (Pubitemid 20248492)
22. Stergiou GS, Lourida P, Tzamouranis D, Baibas NM. Unreliable oscillometric blood pressure measurement: Prevalence, repeatability and characteristics of the phenomenon. J Hum Hypertens 2009; 23: 794-800.
23. Hansson L, Zanchetti A, Carruthers SG, Dahlöf B, Elmfeldt D, Julius S et al. Effects of intensive bloodpressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998; 351: 1755-1762. (Pubitemid 28269185)
24. Julius S, Kjeldsen SE, Weber M, Brunner HR, Ekman S, Hansson L et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: The VALUE trial. Lancet 2004; 363: 2022-2031. (Pubitemid 38781102)
25. Dahlöf B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet 2005; 366: 895-906. (Pubitemid 41265663)
26. Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 2008; 358: 1547-1559. (Pubitemid 351522739)
27. Lithell H, Berglund L. Validation of an oscillometric blood pressure measuring device: A substudy of the HOT Study. Hypertension optimal treatment. Blood Press 1998; 7: 149-152. (Pubitemid 28419511)
28. O'Brien E, Atkins N, Stergiou G, Karpettas N, Parati G, Asmar R et al. European Society of Hypertension International Protocol revision 2010 for the validation of blood pressure measuring devices in adults. Blood Press Monit 2010; 15: 23-38.
29. Ostchega Y, Nwankwo T, Sorlie PD, Wolz M, Zipf G. Assessing the validity of the Omron HEM-907XL oscillometric blood pressure measurement device in a national survey environment. J Clin Hypertens 2010; 12: 22-28.